Success Stories: An Associate Professor from Pakistan Secured I-140 (NIW) Approval in the Field of Biotechnology

 

Client’s Testimonial:

“Thank you so much. I am always indebted to the effort you have made in making it a success. I would really like to recommend this firm to every individual on the Globe for preparing and filing such cases.”


On April 8th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Professor in the Field of Biotechnology (Approval Notice).


General Field: Biotechnology

Position at the Time of Case Filing: Associate Professor

Country of Origin: Pakistan

Approval Notice Date: April 8th, 2021

Processing Time: 9 months, 12 days


Case Summary:

Holder of a Ph.D. in biotechnology, an associate professor hired North America Immigration Law Group to help him in filing an EB-2 NIW (National Interest Waiver) petition. Before taking our client’s case, we assessed his qualification and expertise in the field. After a complete evaluation, we confirmed the veracity of his credentials and aimed at preparing a credible case on his behalf to be represented to the USCIS. Our objective was to convince USCIS of our client’s work as a boon to both the pharmaceutical and healthcare industries in the U.S. Thus, we included the following in his petition pack:

  • Formerly, we detailed his proposed research, which focuses on applying phototherapeutic biotechnology approaches such as physical sensors and light-activated nanoparticles to treat cancer and infectious diseases, which has great importance because it involves the development of metal nanoparticles for application in tools used to treat diseases. We also noted that his research has been supported through funding from the Higher Education Commission of Pakistan. Such support by an international agency demonstrates the importance of his research on a global scale.
  • Further, we noted the 48 peer-reviewed journal articles (6 first-authored and 1 co-first-authored) and 1 book chapter he had published in the top journals in the biotechnology field, which impressively garnered 973 citations, reflecting his major influence on other scholars’ in understanding the topics relating to the field. Besides, we analyzed that many of his writings have been among the most cited in the field, suggesting both the originality and significance of his methods and results. He had been frequently invited to conduct peer reviews for prominent journals as well, and he has completed 35 peer reviews to date, further confirming his transcendent standing in his area of research.
  • To corroborate further, we added four letters of support, obtained by our client’s fellow experts. They provided more insights into his work. One of them stated:
“In the United States, the biopharmaceutical industry accounts for over a trillion dollars in yearly sales, of which the biotechnology sector represents a large portion. Producing large profits and occupying a key position in the United States economy, the biopharmaceutical industry is an invaluable component of the nation’s economic portfolio… [Client’s] work to develop useful devices for monitoring of cellular processes makes his experimentation vital to the continued economic stability and success of the United States medical sector. Thus, his work is highly valuable to the nation.”

We persuaded the USCIS with our petition presentation, and our client received his NIW approval within 9 months and 12 days. We truly thank him for trusting us with his EB-2 NIW petition. Also, we wish him well as he advances in his chosen field.